bioAffinity Technologies Statistics
Total Valuation
BIAF has a market cap or net worth of $3.89 million. The enterprise value is $2.89 million.
| Market Cap | 3.89M |
| Enterprise Value | 2.89M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026, before market open.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BIAF has 1.28 million shares outstanding. The number of shares has increased by 578.55% in one year.
| Current Share Class | 1.28M |
| Shares Outstanding | 1.28M |
| Shares Change (YoY) | +578.55% |
| Shares Change (QoQ) | +16.29% |
| Owned by Insiders (%) | 6.63% |
| Owned by Institutions (%) | 4.36% |
| Float | 1.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.66 |
| Forward PS | 0.94 |
| PB Ratio | 0.36 |
| P/TBV Ratio | 2.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.38.
| Current Ratio | 1.44 |
| Quick Ratio | 1.24 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -276.15 |
Financial Efficiency
Return on equity (ROE) is -1,860.15% and return on invested capital (ROIC) is -414.08%.
| Return on Equity (ROE) | -1,860.15% |
| Return on Assets (ROA) | -125.11% |
| Return on Invested Capital (ROIC) | -414.08% |
| Return on Capital Employed (ROCE) | -250.72% |
| Weighted Average Cost of Capital (WACC) | -1.27% |
| Revenue Per Employee | $103,526 |
| Profits Per Employee | -$266,408 |
| Employee Count | 57 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 61.08 |
Taxes
In the past 12 months, BIAF has paid $6,363 in taxes.
| Income Tax | 6,363 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.89% in the last 52 weeks. The beta is -1.25, so BIAF's price volatility has been lower than the market average.
| Beta (5Y) | -1.25 |
| 52-Week Price Change | -91.89% |
| 50-Day Moving Average | 6.22 |
| 200-Day Moving Average | 19.33 |
| Relative Strength Index (RSI) | 34.78 |
| Average Volume (20 Days) | 1,964,114 |
Short Selling Information
The latest short interest is 66,654, so 5.20% of the outstanding shares have been sold short.
| Short Interest | 66,654 |
| Short Previous Month | 115,467 |
| Short % of Shares Out | 5.20% |
| Short % of Float | 5.56% |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, BIAF had revenue of $5.90 million and -$15.19 million in losses. Loss per share was -$59.70.
| Revenue | 5.90M |
| Gross Profit | 2.04M |
| Operating Income | -12.38M |
| Pretax Income | -15.18M |
| Net Income | -15.19M |
| EBITDA | -11.97M |
| EBIT | -12.38M |
| Loss Per Share | -$59.70 |
Balance Sheet
The company has $2.43 million in cash and $1.44 million in debt, with a net cash position of $994,714 or $0.78 per share.
| Cash & Cash Equivalents | 2.43M |
| Total Debt | 1.44M |
| Net Cash | 994,714 |
| Net Cash Per Share | $0.78 |
| Equity (Book Value) | 3.77M |
| Book Value Per Share | 8.34 |
| Working Capital | 1.18M |
Cash Flow
In the last 12 months, operating cash flow was -$11.47 million and capital expenditures -$91,988, giving a free cash flow of -$11.56 million.
| Operating Cash Flow | -11.47M |
| Capital Expenditures | -91,988 |
| Depreciation & Amortization | 413,093 |
| Net Borrowing | -248,167 |
| Free Cash Flow | -11.56M |
| FCF Per Share | -$9.01 |
Margins
Gross margin is 34.61%, with operating and profit margins of -209.82% and -257.33%.
| Gross Margin | 34.61% |
| Operating Margin | -209.82% |
| Pretax Margin | -257.23% |
| Profit Margin | -257.33% |
| EBITDA Margin | -202.82% |
| EBIT Margin | -209.82% |
| FCF Margin | n/a |
Dividends & Yields
BIAF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -578.55% |
| Shareholder Yield | -578.55% |
| Earnings Yield | -1,970.14% |
| FCF Yield | -297.39% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 24, 2026. It was a reverse split with a ratio of 1:15.
| Last Split Date | Aug 24, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
BIAF has an Altman Z-Score of -17.01 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.01 |
| Piotroski F-Score | 4 |